Publications

	Jul 2008 Forging Key Opinion Leader Relationships: Developing the Next Generation

	Key Opinion Leader (KOL) involvement in a therapy area, drug class or product is an essential component of any pharmaceutical marketing campaign. They have the expertise and the authority to convey information to healthcare professionals and patients in a way that marketers simply cannot. Successful working relationships with KOLs can deliver a wide range of benefits including improved credibility and third party endorsement for a product’s characteristics. But it is absolutely crucial that KOLs maintain their independence and avoid being seen as supporting one brand or company over any other. It is equally important for a pharmaceutical company to ... View

Jul 2008

Forging Key Opinion Leader Relationships: Developing the Next Generation

Key Opinion Leader (KOL) involvement in a therapy area, drug class or product is an essential component of any pharmaceutical marketing campaign. They have the expertise and the authority to convey information to healthcare professionals and patients in a way that marketers simply cannot.

Successful working relationships with KOLs can deliver a wide range of benefits including improved credibility and third party endorsement for a product’s characteristics. But it is absolutely crucial that KOLs maintain their independence and avoid being seen as supporting one brand or company over any other. It is equally important for a pharmaceutical company to ...

View

	Jul 2008 Learning programmes – more interactivity please!

	In the changing climate of what constitutes acceptable medical education, the emphasis is now on offering true learning opportunities for customers. But whether it is for professionals, patients or internal audiences, the trick is in selecting which educational tactic or tactics to use. In this article we look at both external and internal audiences for med ed and assess the sorts of learning programmes that can work for each. We also look at the place for interactive solutions and suggest why these now hold a core position in effective medical education. View

Jul 2008

Learning programmes – more interactivity please!

In the changing climate of what constitutes acceptable medical education, the emphasis is now on offering true learning opportunities for customers. But whether it is for professionals, patients or internal audiences, the trick is in selecting which educational tactic or tactics to use. In this article we look at both external and internal audiences for med ed and assess the sorts of learning programmes that can work for each. We also look at the place for interactive solutions and suggest why these now hold a core position in effective medical education.

View

	Jul 2008 Running successful primary care meetings in 2006

	The primary care meeting has proved time and time again to be an invaluable opportunity for building closer relationships with customers, addressing local issues and effecting change though providing primary care health professionals with the chance to meet with national and international specialists. With the ABPI restrictions and intense focus on pharmaceutical activities following the Health Select Committee report, it is more important than ever that the meeting itself is truly a quality event (although this should always have been the case). View

Jul 2008

Running successful primary care meetings in 2006

The primary care meeting has proved time and time again to be an invaluable opportunity for building closer relationships with customers, addressing local issues and effecting change though providing primary care health professionals with the chance to meet with national and international specialists. With the ABPI restrictions and intense focus on pharmaceutical activities following the Health Select Committee report, it is more important than ever that the meeting itself is truly a quality event (although this should always have been the case).

View

	Jul 2008 The need for pharma-sponsored medical education

	Both doctors and the general public have, in the past, been sceptical about the possible bias of pharma-sponsored medical and disease area information. Many doctors will not attend pharma-sponsored meetings or symposia unless they are interested in hearing new trial data or they can gain points for their ongoing professional development. For generic education regarding a therapy area, they may seek something they consider to be unbiased – like their own professional bodies or the BMJ Learning resources. View

Jul 2008

The need for pharma-sponsored medical education

Both doctors and the general public have, in the past, been sceptical about the possible bias of pharma-sponsored medical and disease area information. Many doctors will not attend pharma-sponsored meetings or symposia unless they are interested in hearing new trial data or they can gain points for their ongoing professional development. For generic education regarding a therapy area, they may seek something they consider to be unbiased – like their own professional bodies or the BMJ Learning resources.

View

Login

Publications